Researchers found shared genetic factors between Alzheimer's disease and high blood lipid levels, suggesting potential for early diagnosis and targeted therapies. The study analyzed 1.5 million individuals and identified specific DNA variants that increase the risk of developing both conditions.
A systematic review and meta-analysis of 19 studies found that people with the highest anthocyanin intake were 9% less likely to suffer from coronary heart disease. Anthocyanins have also been linked to improved risk factors for heart disease, such as cholesterol levels and blood pressure.
The Lyme Disease Biobank now accepts tissue donations from patients undergoing knee-replacements and similar surgeries, as well as patients who die with Lyme disease. Researchers aim to explore the ability of Lyme bacteria to invade tissues and organs, leading to medical breakthroughs in diagnosis and treatment.
A study published in Science Translational Medicine found that removing the appendix early in life can lower the risk of developing Parkinson's disease. The appendix acts as a reservoir for disease-associated proteins, and appendectomy delays disease progression by an average of 3.6 years.
A new study predicts that rising temperatures will lead to a significant increase in Lyme disease cases in the United States. By mid-century, it is expected to rise by 21%, resulting in an additional 8.6 cases of Lyme disease per 100,000 people annually.
Researchers have developed new techniques to detect Lyme disease bacteria weeks sooner than current tests, indicating active infection and enabling quicker treatment. The new direct tests detect DNA or protein from Borrelia burgdorferi, increasing the accuracy of an early diagnosis.
Researchers found that low colonic miR-31 expression is associated with worse disease outcomes in adults and future development of strictures in children. This discovery has the potential to improve clinical trial designs and develop more personalized therapeutic strategies for Crohn's disease patients.
Case Western Reserve researchers are investigating skin prions as a potential diagnostic biomarker for Creutzfeldt-Jakob disease. The study aims to determine if skin prions can serve as a pre-mortem and post-mortem diagnostic tool, as well as explore their role in transmission between humans.
A recent symposium will review the current criteria for diagnosing Alzheimer's disease, highlighting the need to rethink diagnostic approaches. The event also explores how brain metabolism changes in women after menopause may increase their risk of developing Alzheimer's.
A large-scale international study published in PLOS Medicine found that a new medication called Nilvadipine showed promise in slowing the progression of mild and moderate Alzheimer's disease. However, the overall group of patients did not benefit from the treatment. Further research is needed to explore its potential.
A new study published in Neurology shows that amyotrophic lateral sclerosis (ALS) affects the mind, especially later in the disease, leading to cognitive and behavioral problems such as apathy, changes in eating behaviors, and loss of sympathy or empathy. People with ALS are recommended to be routinely screened for these issues.
A study published in Canadian Medical Association Journal found that patients with acute critical illness without pre-existing kidney disease are at increased risk of developing chronic kidney disease and end-stage renal disease. The study also shows that these patients have a higher risk of death.
Researchers at the University of Tennessee suggest that a genetic mutation may cause Huntington's disease to appear earlier in life. A new drug, Panobinostat, may regulate gene expression and prevent disease progression.
A comprehensive analysis of the evidence found exposure to toxic metals like arsenic, lead, copper, and cadmium to be associated with an increased risk of cardiovascular disease. The study suggests that these metals may be an independent risk factor for cardiovascular disease, even at relatively low levels of exposure.
Researchers analyzed data from over 5,700 pregnant women with heart disease and found that fewer deaths occurred during pregnancy compared to previous years. However, nearly one in ten women with pulmonary arterial hypertension died during pregnancy or early post-partum. Pre-pregnancy counseling is crucial to identify high-risk patients.
Guidelines recommend inducing labour or caesarean section at 40 weeks to minimize pregnancy risks, particularly for women with congenital heart disease. Women with heart disease face higher mortality risk during pregnancy compared to healthy counterparts.
Chagas disease, caused by a parasite, has spread to the US and other countries, carrying a high risk of heart disease. Early detection is critical for treatment, which can be cured with medications having a 60-90% success rate.
A new study has found that the thinning of the retina is linked to the loss of brain cells that produce dopamine, a substance that helps control movement. This discovery may lead to a simple eye scan being used to detect Parkinson's disease in its earliest stages.
A new stem cell model developed by City of Hope researchers provides insight into the disease pathway of Alexander disease, a rare nervous system disorder. The study found that therapies targeting CHI3L1 protein may be able to treat Alexander's disease or leukodystrophic diseases.
A new system has been identified that could reduce neurodegeneration in Huntington's disease by blocking the accumulation of toxic protein aggregates. The system involves a protein called UBR5, which promotes the degradation of mutant huntingtin, leading to a decrease in neurotoxic effects.
Researchers found that LRRK2 protein activity may contribute to Parkinson's disease development in up to three percent of patients without gene mutations. The study identified LRRK2 as a key player in neurobiological pathways affected by the disease.
Researchers at McMaster University have discovered a unique type of signaling from damaged DNA that triggers huntingtin activity in DNA repair. This signaling is defective in Huntington's disease and can be restored with a molecule called N6-furfuryladenine, reversing symptoms and restoring mutant huntingtin protein levels to normal.
Researchers at Washington University School of Medicine have developed a gene therapy method to target damaged kidney cells, which could lead to improved treatment for chronic kidney disease. The approach uses adeno-associated virus (AAV) to deliver genetic material to targeted cells, showing promise in slowing or reversing cell damage.
Nonalcoholic fatty liver disease (NAFLD) has a significant impact on the US healthcare system, with estimated annual costs of $32 billion. The prevalence of NAFLD mirrors the rising trend of obesity in the United States, affecting roughly 100 million Americans.
A new study implicates viral presence in the brain as a risk factor for Alzheimer's disease. Researchers found high levels of human herpesvirus 6A and 7 in brain samples from individuals with AD neuropathology, suggesting potential triggers and targets for treatment.
University of Michigan researchers have made a breakthrough in treating Spinocerebellar ataxia type 3 (SCA3) using gene silencing technology. They successfully reduced mutant RNA levels without toxic effects, offering hope for disease-slowing therapy.
A study published in Radiology found that children with chronic kidney disease exhibit increased cerebral blood flow compared to healthy controls. This may indicate compensatory hyperactivity or disturbances in blood flow regulation, potentially leading to white matter injury and cognitive problems.
The USPSTF recommends against adding ECG screening to standard risk assessment to prevent CVD events in asymptomatic adults at low risk. Cardiovascular disease is a leading cause of death among adults in the United States, but ECG screening has not been proven to reduce CVD events.
A higher testosterone to estradiol ratio is associated with an elevated risk of cardiovascular disease, coronary heart disease, and heart failure. Higher total testosterone levels are linked to an increased risk of coronary heart disease and total cardiovascular disease.
A new University of Guelph study has discovered that exposure to pesticides like paraquat and maneb increases the risk of developing Parkinson's disease. Low-level pesticide exposure disrupts cells in a way that mimics genetic mutations, drastically increasing disease onset risk.
Patients with inflammatory bowel disease (IBD) are at a 22% higher risk of developing Parkinson's disease compared to non-IBD individuals. Researchers found this association independent of age, gender, and length of follow-up.
A recent study from the University of Pennsylvania found that dogs born between June and August are at higher risk of heart disease. The research suggests that exposure to fine air particulates during pregnancy may play a role in later development of heart disease.
Research by Dr. Fernanda De Felice reveals a disease mechanism common to Alzheimer's disease and Type 2 diabetes, leading to new strategies for preserving brain health. The discovery identifies a pathway causing inflammation in the brain, affecting insulin signaling and endoplasmic reticulum stress.
Researchers found that a defective protein in Huntington's disease disrupts the mTORC1 pathway, leading to cardiac problems. Adjusting this pathway improved heart function in experimental animals, offering new insights into the biology of the disease.
A recent Mount Sinai study reveals individuals with IBD have a 28% higher risk of developing Parkinson's disease; treated patients show significant reduction in risk after anti-TNFα therapy. The study suggests exploring anti-TNFα to prevent Parkinson's disease in high-risk individuals.
Research found a link between poorer health-related quality of life in adolescence and increased risk of cardiovascular disease. Adolescents with lower scores in social and mental well-being domains had structural changes in their retinal blood vessels, which could be indicative of future cardiovascular disease risk.
The Critical Path Institute has received a $10 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to identify unmet needs for biomarker development in Crohn's disease. The pre-consortium will focus on laying the groundwork for future regulatory endorsement and accelerate the development of new treatments.
A new blood test has been developed to detect early indicators of Alzheimer's disease, measuring the relative amounts of pathological and healthy amyloid-beta forms in the blood. The test was found to reliably detect signs of the disease on average eight years before diagnosis, with an overall diagnostic accuracy of 86%.
A recent study published at the American College of Cardiology meeting found a significant link between Inflammatory Bowel Disease (IBD) and an increased risk of heart attacks. The research revealed that IBD is associated with higher odds of having a heart attack, especially in younger patients.
A study by the American College of Cardiology found a strong correlation between geographic and seasonal trends in coronary heart disease hospitalizations and internet search queries. The research suggests that search data can be a useful resource for tracking heart disease over time and in different regions.
Researchers have developed a safer and more specific CRISPR/Cas9 system to treat Huntington's disease, a neurodegenerative disorder caused by a defective gene. The new technique successfully inactivates the mutant gene and reduces toxic protein synthesis, offering hope for a potential cure.
Research reveals that individuals with Alzheimer's disease who die from the condition itself tend to have less hospitalization and ICU stays compared to those who die from other causes. This contrasts with those who receive fewer palliative care services during their final months.
A review published in the Journal of the American College of Cardiology suggests that environmental noise, including traffic noise, may contribute to the development of heart disease. The study proposes that noise induces a stress response, leading to vascular damage and increased risk of hypertension and diabetes.
Researchers found that soils with more than 18% clay are associated with a steep drop in cases of chronic wasting disease. Additionally, soils with pH above 6.6 also show higher incidence rates of the disease. These findings could inform future management schemes to prevent disease transmission.
USC researchers found that nearly 50% of dementias begin with damaged gatekeeper cells, leading to small vessel disease and white matter disease. Controlling fibrinogen levels may reverse or slow white matter disease in a mouse model.
Scientists at Joslin Diabetes Center found a connection between eye damage and cardiovascular disease in people with type 1 diabetes, suggesting shared biological mechanisms. The study also showed that kidney disease was not necessarily linked to cardiovascular disease, challenging previous assumptions.
A study published in The BMJ reveals that chronic diseases, such as heart disease and diabetes, significantly increase cancer risk, accounting for over one-fifth of new cancer cases. Regular physical activity was found to reduce this risk by nearly 40%.
Researchers found a higher frequency of LRRK2 gene mutations in Ashkenazi Jewish patients with Crohn's disease, which also increases the risk of developing Parkinson's disease. The study's findings could lead to better understanding and treatment of both conditions.
Researchers found that people with Parkinson's disease had significantly lower caffeine levels in their blood, even if they consumed the same amount as those without the disease. The study suggests a simple test for early diagnosis could be developed using caffeine levels.
Researchers at Boston University School of Medicine discovered a possible biomarker for Huntington's disease, which may help evaluate treatment effectiveness and potentially delay disease onset. The study found altered levels of microRNAs in individuals carrying the HD gene mutation twenty years before symptoms appear.
The new guidelines recommend a set of blood tests to diagnose patients with liver disease, including bilirubin, albumin, and liver enzymes. They also provide guidance on how to manage patients with abnormal test results, aiming to reduce unnecessary repeat testing for those unlikely to have significant liver disease.
A new study reveals a significant association between erectile dysfunction and impaired endothelial function, as well as increased carotid intimal medial thickness, indicating an early manifestation of atherosclerosis. The findings support a more aggressive CV disease risk assessment and management for persons with erectile dysfunction.
A new study by NYU College of Global Public Health and the University of Michigan found no evidence of an 'obesity paradox' among people with new cases of cardiovascular disease. This contradicts prior research that suggested obesity may be associated with improved survival in people with existing cardiovascular disease. The study used...
A comprehensive study found that inflammatory bowel disease has become a global disease with accelerating incidence in newly industrialized countries. The research highlights the need for prevention and preparedness measures as these countries struggle to manage this complex and costly disease.
A study found that a cancer medication can improve symptoms of Huntington's disease in mice, including increased mobility and longer lifespan. The drug targets mitochondrial health and protein removal, also relevant to other neurodegenerative disorders.
A study has found a connection between genetic mutations in lysosomal storage disorders and an increased risk of developing Parkinson's disease. Researchers analyzed the largest available Parkinson's disease genetic dataset, discovering that nearly half of those with the disease carried damaging mutations in these genes.
A recent study published in PLOS Medicine reveals that HIV patients are at a higher risk of both chronic kidney disease and cardiovascular disease. The research found that nearly 11% of patients experienced both conditions within one year of each other.
A phase 3 trial found tolvaptan slows the rate of decline in kidney function in patients with autosomal dominant polycystic kidney disease. The condition affects millions in the US and has no cure. The drug targets a mechanism contributing to cyst growth, potentially delaying transplant or dialysis need.
Patients with psoriasis are at a higher risk of developing serious liver disease compared to those with rheumatoid arthritis, according to a large population-based study. The study found that systemic inflammation plays a significant role in the development of liver disease in these patients.
Researchers are studying the relationship between gut bacteria and Parkinson's disease, aiming to identify early signs of the illness. The study aims to compare the gut bacteria of people in the earliest stages of the disease with those who are healthy.